Ceftazidim-avibactam susceptibility of carbapenemase producing enterobacterales in an OXA-48 endemic area
Background: Carbapenem-resistant Enterobacterales (CRE) are included in the critical priority pathogens by WHO. OXA-48 is the predominating carbapenemase in Türkiye, in where carbapenem resistance rates are high, particularly in Klebsiella pneumoniae isolates. Ceftazidime-Avibactam (CAZ-AVI) has bee...
Saved in:
| Main Authors: | Şevval Arduç Tok, Ayşe Barış, Leyla Genç, Hanife Tutan, Elif Aktaş |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Journal of Global Antimicrobial Resistance |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2213716524002807 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ceftazidime–Avibactam Versus Polymyxin-Based Combination Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48-Endemic Region
by: Rıdvan Dumlu, et al.
Published: (2024-10-01) -
Epidemiological and genetic characteristics of clinical carbapenemase-producing Enterobacterales isolates from Batna hospitals in Algeria
by: Amel Benbouza, et al.
Published: (2024-12-01) -
The importance of monitoring a new antibiotic: ceftazidime/avibactam usage and resistance experience from England, 2016 to 2020
by: Berit Muller-Pebody
Published: (2025-04-01) -
Assessment of in vitro activity of ceftazidime/avibactam on carbapenemase‐producing Enterobacterales from Iran: An experimental study
by: Mehri Haeili, et al.
Published: (2024-08-01) -
In Vitro Efficacy of Ceftazidime-avibactam Against blaOXA-48-producing Klebsiella pneumoniae Isolates
by: Yasemin ÇAĞ, et al.
Published: (2023-11-01)